EchoWear: Smartwatch technology for voice and speech treatments of patients with Parkinson's disease

Proceedings - Wireless Health 2015, WH 2015

Volumn , Issue , 2015, Pages

  Dubey, Harishchandra ^a   Goldberg, Jon C ^a   Abtahi, Mohammadreza ^a   Mahler, Leslie ^b   Mankodiya, Kunal ^a  

^a The University of Rhode Island   (United States)

^b UNIVERSITY OF RHODE ISLAND   (United States)

Author keywords

Dysarthria; Knowledge based speech processing; Parkinson's disease; Smartwatch; Speech therapy; Wearable system

Indexed keywords

AUDIO EQUIPMENT; CONTINUOUS SPEECH RECOGNITION; DISEASE CONTROL; KNOWLEDGE BASED SYSTEMS; NEURODEGENERATIVE DISEASES; PATIENT TREATMENT; SPEECH; SPEECH COMMUNICATION; SPEECH PROCESSING; WEARABLE COMPUTERS;

DYSARTHRIA; KNOWLEDGE BASED; PARKINSON'S DISEASE; SMARTWATCH; SPEECH THERAPY; WEARABLE SYSTEMS;

SPEECH INTELLIGIBILITY;

EID: 84962832702     PISSN: None     EISSN: None     Source Type: Conference Proceeding    
DOI: 10.1145/2811780.2811957     Document Type: Conference Paper

References (41)

1. DeLau, L.M., and Breteler, M.M. Epidemiology of Parkinson's disease. Lancet Neurol 2006; 5(6):525-535. DOI=10.1016/S1474-4422(06)70471-9.
2. Dorsey, E.R., Constantinescu, R., Thompson, J.P., Biglan, K.M., Holloway, R.G., Kieburtz, K., Marshall, F.J., Ravina, B.M., Schifitto, G., Siderowf, A., and Tanner, C.M. Projected number of people with Parkinson disease in the most populous nations, 2005 through 2030. Neurology 2007;68:384-6. DOI= http://dx.doi.org/10.1212/01.wnl.0000247740.47667.03.
3. Hartelius, L., and Svensson, P. Speech and swallowing symptoms associated with Parkinson's disease and multiple sclerosis: a survey. Folia PhoniatrLogop 1994, 46(1):9-17. DOI= http://dx.doi.org/10.1159/000266286.
4. Hoa, A.K., Iansek, R., Marigliani, C., Bradshaw, J.L. and Gates, S. Speech impairment in a large sample of patients with Parkinson's disease. Behavioural neurology, 11(3), (1999), 131-137. DOI= http://dx.doi.org/10.1155/1999/327643.
5. A. K., Iansek, R., and Bradshaw, J. L. Motor instability in parkinsonian speech intensity. Cognitive and Behavioral Neurology, 14(2), (2001), 109-116.
6. Baumgartner, C. A., Sapir, S., and Ramig, L. O. Voice quality changes following phonatory-respiratory effort treatment (LSVT®) versus respiratory effort treatment for people with Parkinson disease. Journal of Voice, 15(1), (2001), 105-114. DOI = http://dx.doi.org/10.1016/S0892-1997(01)00010-8.
7. Sapir, S., Spielman, J. L., Ramig, L. O., Story, B. H., and Fox, C. Effects of intensive voice treatment (the Lee Silverman Voice Treatment [LSVT] on vowel articulation in dysarthric individuals with idiopathic Parkinson disease: acoustic and perceptual findings. Journal of Speech, Language, and Hearing Research, 50(4), (2007), 899-912. DOI = 10.1044/1092-4388(2007/064).
8. Forrest, K., Weismer, G., and Turner, G. S. Kinematic, acoustic, and perceptual analyses of connected speech produced by Parkinsonian and normal geriatric adults. The Journal of the Acoustical Society of America, 85(6), (1989), 2608-2622. DOI=http://dx.doi.org/10.1121/1.397755.
9. Duffy J. R., Motor Speech Disorders: Substrates, Differential Diagnosis, and Management (Third Edition), Elsevier Health Sciences, 2013; 165-189.
10. Damier, P., Hirsch, E.C., Agid, Y., Graybiel, A.M. The substantianigra of the human brain II. Patterns of loss of dopamine-containing neurons in Parkinson's disease. Brain 122, ( 1999), 1437-1448.
11. Ahlskog, J. E. Beating a dead horse dopamine and Parkinson disease. Neurology, 69(17), (2007), 1701-1711. DOI = 10.1212/01.wnl.0000296942.14309.4a.
12. Braak, H., Ghebremedhin, E., Rüb, U., Bratzke, H., and Del Tredici, K. Stages in the development of Parkinson's disease-related pathology. Cell and tissue research, 318(1), (2004), 121-134. DOI =10.1007/s00441-004-0956-9.
13. Perez, K. S., Ramig, L. O., Smith, M. E., and Dromey, C. The Parkinson larynx: tremor and videostroboscopic findings. Journal of Voice, 10(4), (1996), 354-361. DOI = 10.1016/S0892-1997(96)80027-0.
14. Smith, M. E., Ramig, L. O., Dromey, C., Perez, K. S., and Samandari, R. Intensive voice treatment in Parkinson disease: laryngostroboscopic findings. Journal of Voice, 9(4), (1995), 453-459. DOI = 10.1016/S0892-1997(05)80210-3.
15. Baker, K. K., Ramig, L. O., Luschei, E. S., and Smith, M. E. Thyroarytenoid muscle activity associated with hypophonia in Parkinson disease and aging. Neurology, 51(6), (1998), 1592-1598. DOI= 10.1212/WNL.51.6.1592.
16. Vincken, W. G., Gauthier, S. G., Dollfuss, R. E., Hanson, R. E., Darauay, C. M., and Cosio, M. G. Involvement of upper-airway muscles in extrapyramidal disorders, a cause of airflow limitation. New England Journal of Medicine, 311(7), (1984), 438-442. DOI = 10.1056/NEJM198408163110704.
17. Solomon, N. P., and Hixon, T. J. Speech breathing in Parkinson's disease. Journal of Speech, Language, and Hearing Research, 36(2), (1993), 294-310. DOI = 10.1044/jshr.3602.294.
18. Bartels, A. L., and Leenders, K. L. Parkinson's disease: the syndrome, the pathogenesis and pathophysiology. Cortex; 45(8), (2009), 915-921. DOI =http://dx.doi.org/10.1016/j.cortex.2008.11.010.
19. Berardelli, A., Rothwell, J. C., Thompson, P. D., and Hallett, M. Pathophysiology of bradykinesia in Parkinson's disease. Brain, 124, (2001), 2131-2146. DOI= http://dx.doi.org/10.1093/brain/124.11.2131.
20. Sapir, S., Ramig, L. O., and Fox, C. M. Intensive voice treatment in Parkinson's disease: Lee Silverman Voice Treatment. Expert Review of Neurotherapeutics, 11(6), (2011), 815-830. DOI=10.1586/ern.11.43.
21. Desmurget, M., Grafton, S. T., Vindras, P., Grea, H., and Turner, R. S. The basal ganglia network mediates the planning of movement amplitude. European Journal of Neuroscience, 19(10), (2004), 2871-2880. DOI = 10.1111/j.0953-816X.2004.03395.x.
22. Schneider, J. S., Diamond, S. G., and Markham, C. H. Deficits in orofacial sensorimotor function in Parkinson's disease. Annals of neurology, 19(3), (1986), 275-282. DOI =10.1002/ana.410190309.
23. Ramig, L. O., Sapir, S., Fox, C., and Countryman, S. Changes in vocal loudness following intensive voice treatment (LSVT) in individuals with Parkinson's disease: A comparison with untreated patients and normal age-matched controls. Movement Disorders, 16(1), (2001), 79-83. DOI = 10.1002/1531-8257(200101)16:1〈79::AID-MDS1013〉3.0.CO;2-H.
24. Ramig, L. O., Sapir, S., Countryman, S., Pawlas, A. A., O'Brien, C., Hoehn, M., and Thompson, L. L. Intensive voice treatment (LSVT) for patients with Parkinson's disease: A 2 year follow up. Journal of Neurology, Neurosurgery & Psychiatry, 71(4), (2001), 493-498. DOI = 10.1136/jnnp.71.4.493.
25. Fox, C., Ebersbach, G., Ramig, L., and Sapir, S LSVT LOUD and LSVT BIG: behavioral treatment programs for speech and body movement in Parkinson disease. Parkinson's Disease (2012). DOI = http://dx.doi.org/10.1155/2012/391946.
26. Cherney L.R., and van Vuuren, S. Telerehabilitation, Virtual Therapists, and Acquired Neurologic Speech and Language Disorders. Seminars in speech and language. 2012; 33(3):243-257. DOI= 10.1055/s-0032-1320044.
27. Theodoros, D. G. Telerehabilitation for service delivery in speech-language pathology. Journal of Telemedicine and Telecare 14.5 (2008): 221-224. DOI = 10.1258/jtt.2007.007044.
28. Goetz, C.G., Stebbins, G.T., Wolff, D., DeLeeuw, W., Bronte-Stewart, H., Elble, R., Hallett, M., Nutt, J., Ramig, L., Sanger, T., Wu, A.D., Kraus, P.H., Blasucci, L.M., Shamim, E.A., Sethi, K.D., Spielman, J., Kubota, K., Grove, A.S., Dishman, E., & Taylor, C.B. (2009). Testing objective measures of motor impairment in early Parkinson's disease: Feasibility study of an at-home testing device. Movement Disorders, 24(4), 551-556. DOI =10.1002/mds.22379.
29. Ogunfunmi, T., and Narasimha, M. Principles of Speech Coding (1st ed.), 2010, CRC Press, Inc., Boca Raton, FL, USA.
30. Berouti, M., Schwartz, R., and Makhoul, J. Enhancement of speech corrupted by acoustic noise. Acoustics, Speech, and Signal Processing, IEEE International Conference on ICASSP'79. Vol. 4. IEEE, 1979. DOI = 10.1109/ICASSP.1979.1170788.
31. Martin, R. Noise power spectral density estimation based on optimal smoothing and minimum statistics. Speech and Audio Processing, IEEE Transactions on 9.5 (2001): 504-512. DOI = 10.1109/89.928915.
32. Gerkmann, T. and Hendriks, R.C. Unbiased MMSE-based noise power estimation with low complexity and low tracking delay. Audio, Speech, and Language Processing, IEEE Transactions on 20.4 (2012): 1383-1393. DOI = 10.1109/TASL.2011.2180896.
33. http://www.bksv.com/Products/handheld-instruments/sound-level-meters/sound-level-meters/type-2239-a.
34. Brigham, E. O. The Fast Fourier Transform and its Applications. Vol. 1. Englewood Cliffs, NJ: Prentice Hall, 1988.
35. Fastl, H., Volk, F., Straubinger, M. Standards for calculating loudness of stationary or time-varying sounds. Proc. InterNoise 2009.
36. Fastl, H., and Zwicker, E. Psychoacoustics: Facts and Models. Vol. 22. Springer Science & Business Media, 2007.
37. Camacho, A., and Harris, J. G. A sawtooth waveform inspired pitch estimator for speech and music. The Journal of the Acoustical Society of America 124.3 (2008): 1638-1652. DOI = http://dx.doi.org/10.1121/1.2951592.
38. Hiremath, S., Yang, G., and Mankodiya, K. Wearable Internet of Things: Concept, architectural components and promises for person-centered healthcare. In Wireless Mobile Communication and Healthcare (Mobihealth), 2014 EAI 4th International Conference on, pp. 304-307. IEEE, 2014. DOI = 10.1109/MOBIHEALTH.2014.7015971.
39. Tjaden, K., and Watling, E., Characteristics of Diadochokinesis in Parkinson's Disease and Multiple Sclerosis, The Journal of the Acoustical Society of America, 111, 2479-2479 (2002), DOI=http://dx.doi.org/10.1121/1.4778609).
40. Watson, P.J., and Munson, B.R., Parkinson's disease and the effect of lexical factors on vowel articulation, The Journal of the Acoustical Society of America, 124, EL291-EL295 (2008), DOI=http://dx.doi.org/10.1121/1.2987464
41. Tjaden, K., Farrens, S., Geaney, K., McRae, P., Nachtman, J., Speaking rate-induced acoustic variability in Parkinson's disease, The Journal of the Acoustical Society of America, 103, 2892-2893 (1998), DOI=http://dx.doi.org/10.1121/1.421817